Companies by HQ LocationTech Companies and Startups Headquartered in Cambridge
207 companies in this collection.
List of companies headquartered in Cambridge
Select...
Loading...
Page NaN of NaN
Displaying companies
Eli is a platform that makes it easy for contractors, installers, and retailers to offer their customers incentives, rebates, and low-interest financing for consumer decarbonization projects. Think heat pump HVAC systems, EV chargers, heat pump hot water h | Cambridge | MA | 10 - 50 | 2023 | $8,600,000 |
VULCAN ELEMENTS is changing the way to electrify aerospace, defense, and auto with decarbonization. | Cambridge | MA | 1 - 200 | 2023 | $5,201,998 |
Sesame Sustainability is a SAAS company that offers industrial decarbonization platform for modeling, optimization, and analysis. | Cambridge | MA | 1 - 10 | 2023 | $2,400,000 |
Symbionics is a brain-computer interface company that focuses on the development of interface devices to integrate humans and machines. | Cambridge | MA | 5 - 20 | 2023 | 4103967 CNY |
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is | Cambridge | MA | 20 - 50 | 2022 | $70,000,000 |
Mantel is developing the first molten-salt based carbon capture technology. Our molten borates are designed to operate at the high temperatures found inside boilers, kilns, and furnaces – enabling highly efficient carbon capture that has not been possible | Cambridge | MA | 5 - 20 | 2022 | $2,000,000 |
Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently d | Cambridge | MA | 20 - 50 | 2022 | $50,000,000 |
Wild Microbes is a next-generation microbial platform that makes everything from plastics to proteins. They develop new microbial strains, making scaling sustainable products faster and cheaper than ever. | Cambridge | MA | 5 - 20 | 2022 | $3,300,000 |
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics. | Cambridge | MA | 20 - 50 | 2022 | $75,000,000 |
Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs. | Cambridge | MA | 10 - 50 | 2022 | $100,000,000 |
Istari makes digital engineering ecosystems a reality where all technologies are created digitally, free from real-world costs, schedules, and environmental impacts. | Cambridge | MA | 20 - 50 | 2022 | $13,000,000 |
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries | Cambridge | MA | 1 - 100 | 2022 | $6,999,999 |
NuMind is a manufacturing company currently based in Cambridge, Massachusetts, United States. It has been founded in 2022 by Etienne Bernard and Samuel Bernard. | Cambridge | MA | 5 - 10 | 2022 | $3,500,000 |
Digital twins are revolutionizing industries from aerospace to agriculture. Istari makes them simple and more secure, unlocking models and simulations for better products - better everything. A faster, cheaper, greener digital future awaits.
With Istari, | Cambridge | MA | 20 - 50 | 2022 | $13,000,000 |
We develop scalable quantum computers to tackle the world’s hardest computational challenges. Join us: https://jobs.polymer.co/atlantic-quantum. | Cambridge | MA | 5 - 20 | 2022 | $10,100,000 |
Tailbox is an MIT-backed startup bringing locations to life through generative AI powered stories. Our location-based social platform for explorers focuses on uncovering hidden gems and unique narratives in every city through immersive storytelling and per | Cambridge | MA | 5 - 10 | 2022 | $1,850,000 |
StataDX is building the world's first point-of-care diagnostics platform for Neurology. | Cambridge | MA | 5 - 10 | 2022 | $2,700,000 |
Foundation Alloy leverage advanced materials technology to design novel alloys optimized for additive manufacturing. | Cambridge | MA | 5 - 10 | 2022 | $10,500,000 |
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. | Cambridge | MA | 20 - 50 | 2022 | $270,000,000 |
Montai is harnessing nature's power through digital technology to treat and prevent chronic disease, hence improving health outcomes for as many people as possible. To address this crucial global concern, the business is pioneering cutting-edge technology | Cambridge | MA | 20 - 50 | 2022 | $50,000,000 |
Sleepagotchi rewards users with a digital collectible for sticking to a consistent sleep schedule that they set for themselves in order to promote healthy sleeping habits. | Cambridge | MA | 10 - 50 | 2022 | $3,500,000 |
Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States. | Cambridge | MA | 5 - 10 | 2022 | $7,000,000 |
Cartwheel offers mental health support to students in order to help schools regain balance in the midst of the student mental health crisis. It works hand in hand to empower school staff, reduce family stress, and improve all students' mental health outcom | Cambridge | MA | 5 - 20 | 2022 | $20,000,000 |
Via Scientific to help scientists and bioinformaticians generate novel science that improves the world. It was founded in 2022. | Cambridge | MA | 10 - 50 | 2022 | $5,000,000 |
Osmoses engages in decarbonizing gas separations to eliminate one gigaton of carbon emissions per year. | Cambridge | MA | 5 - 20 | 2021 | $14,000,000 |
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer | Cambridge | MA | 5 - 10 | 2021 | $90,000,000 |
Gesund.ai orchestrates the AI as-a-Medical Device lifecycle, providing privacy-centered access to diverse yet standardized medical data sources, and a unique analytical toolbox that fosters clinical validation, regulatory clearance and effective marketing. | Cambridge | MA | 20 - 50 | 2021 | $2,000,000 |
Robigo is a biopesticide engineering the plant microbiome to reduce disease in crops. | Cambridge | MA | 5 - 20 | 2021 | $11,150,000 |
Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, | Cambridge | MA | 20 - 100 | 2021 | $205,000,000 |
K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies. | Cambridge | MA | 5 - 20 | 2021 | $100,000,000 |
AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals suffering from both rare and common ailments. | Cambridge | MA | 10 - 50 | 2021 | $30,000,000 |
Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets. | Cambridge | MA | 10 - 50 | 2021 | $80,000,000 |
Thousands of collectors use evaluate.market to analyze NFTs. We are a remote, venture-backed company that is changing how people buy, sell, and analyze digital collectibles. Connect with us on Twitter and join our Discord to learn more. | Cambridge | MA | 10 - 50 | 2021 | $7,291,992 |
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by indust | Cambridge | MA | 500 - 1,000 | 2021 | $550,000,000 |
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications. | Cambridge | MA | 50 - 100 | 2021 | $300,000,000 |
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA. Their First in Class approach for protein editing advances beyond genome editing to direct modification of the proteome. | Cambridge | MA | 20 - 50 | 2021 | $40,000,000 |
Yard Stick measures soil carbon. Scientists and farmers alike know that climate-friendly agricultural practices have the potential to remove atmospheric CO2 at gigaton/year scale. When these practices are adopted, more carbon is stored in soils, improving | Cambridge | MA | 10 - 50 | 2021 | $36,020,856 |
Dianthus is the world’s only AI-first E-commerce company – built from the ground up to help small to medium E-commerce brands. | Cambridge | MA | 5 - 20 | 2021 | $11,500,000 |
FYTO is a technology company that develops systems that grow high quality crops using much less resources. | Cambridge | MA | 5 - 20 | 2021 | $32,959,998 |
Fizz is building a debit card that helps college students in the U.S. started building out their credit without having to learn lessons about overzealous credit use the hard way. | Cambridge | MA | 20 - 50 | 2021 | $125,000 |
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases. | Cambridge | MA | 50 - 200 | 2021 | $134,000,000 |
Stack is a B2B SaaS computer vision information system company that aims to rethink the way warehouses are managed across the United States. | Cambridge | MA | 2 - 10 | 2021 | $500,000 |
Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases. | Cambridge | MA | 20 - 100 | 2021 | $95,000,000 |
Themis AI, a spinoff from CSAIL MIT, was founded by MIT alumni and professors to empower the world to create, advance, and deploy trustworthy AI. Themis' technology enables trustworthy AI in high risk scenarios, rare events and anywhere imbalances and bias | Cambridge | MA | 10 - 50 | 2021 | |
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control | Cambridge | MA | 20 - 50 | 2021 | $100,000,000 |
Fourth Power is an energy storage startup that uses thermal batteries. Through utility-scale thermal storage, the technique transforms renewable energy into an on-demand energy source. | Cambridge | MA | 2 - 10 | 2021 | $19,000,000 |
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel the | Cambridge | MA | 10 - 50 | 2021 | $50,000,000 |
We are reinventing a future Internet. Private. Personal. Relevant. Powered by extraordinary technology. No cookies harmed in the process. | Cambridge | MA | 5 - 10 | 2021 | $1,400,000 |
Novus is a communication technologies company whose products focus on productivity and creativity in content creation using the state-of-the-art approaches in Artificial Intelligence. | Cambridge | MA | 5 - 20 | 2020 | |
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases. The early-stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop e | Cambridge | MA | 50 - 200 | 2020 | $177,000,000 |
Woho enables a new way to build, assembling a team, network, and system to construct from low to high-rise structures with unprecedented quality, precision, and efficiency. The company was founded in 2020 and based in Cambridge, Massachusetts. | Cambridge | MA | 10 - 20 | 2020 | $4,500,000 |
Silvertree is on a mission to empower the world’s aging population. We are developing next-gen wearable technology that provides the right form of safety and connection for active older adults. Aging is a personal experience, yet aging with dignity and ind | Cambridge | MA | 20 - 50 | 2020 | $12,500,000 |
THEON Therapeutics is a patient-focused drug discovery company developing small molecule correctors of RNA pathobiology. The company was founded in 2020 and based in Boston, Massachusetts. | Cambridge | MA | 10 - 50 | 2020 | $13,374,999 |
Standard Biocarbon is produced by pyrolysis of biomass yielding a stable, porous material that is near pure carbon. | Cambridge | MA | 5 - 20 | 2020 | $10,958,317 |
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease. | Cambridge | MA | 20 - 100 | 2020 | $236,000,000 |
Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity. | Cambridge | MA | 50 - 200 | 2020 | $182,000,000 |
Bicara Therapeutics, a wholly-owned subsidiary of Biocon based in Boston, U.S., is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology. Bicara enables access to the thriving innovation ecosystem in the U.S. | Cambridge | MA | 100 - 500 | 2020 | $313,000,000 |
As schools and businesses return to work, they will be met with a number of new challenges: keeping students and employees safe, tracking outbreaks, and communicating to the public that they are taking responsible precautions. CoVerified provides a profe | Cambridge | MA | 10 - 50 | 2020 | |
IoT-enabled analytics platform providing data-driven optimization of industrial liquid systems for manufacturing | Cambridge | MA | 5 - 10 | 2020 | $7,019,999 |
Common Sense Machines is building artificial intelligence that learns to translate the world into a 3D simulation. Our platform, Real-to-Sim-to-Real, leverages the flexibility of human-like learning and the speed and precision of machines to enable one-sho | Cambridge | MA | 5 - 20 | 2020 | $7,579,994 |
Hosta Labs automates the analysis of images and videos of interior structures for property insurance carriers to provide a full in-depth view of accurate replacement values and risks in the underwriting process and on raw material quantities and mitigation | Cambridge | MA | 10 - 50 | 2020 | $14,742,466 |
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease. Founded by world-renowned experts in renal disease, Walden is applying its unique, systems-based approach to address the intersection between the patholo | Cambridge | MA | 20 - 50 | 2020 | $51,000,000 |
Verve's mission is to improve the limits of worker safety and well-being by pioneering the integration of robotics into functional apparel. They commercialize a lightweight, one-size fits most wearable that powers and protects workers all day long, so they | Cambridge | MA | 20 - 50 | 2020 | $35,000,000 |
Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. | Cambridge | MA | 5 - 10 | 2020 | $4,625,000 |
Akooda helps employees to navigate the digital, hybrid, and remote work world using AI and data science. | Cambridge | MA | 10 - 50 | 2020 | $11,000,000 |
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery | Cambridge | MA | 20 - 100 | 2020 | $222,000,000 |
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. | Cambridge | MA | 50 - 200 | 2020 | $107,000,000 |
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise a | Cambridge | MA | 5 - 10 | 2020 | $4,500,000 |
Tagomics transform disease diagnosis through comprehensive multitopic profiling. | Cambridge | MA | 2 - 10 | 2020 | 8463742 GBP |
SalioGen Therapeutics advances in curative genetic therapies using its Exact DNA Integration Technology (EDIT) platform, a mammal-derived genome engineering technology. It is focused on providing durable, safe, and affordable non-viral gene therapies to mo | Cambridge | MA | 20 - 100 | 2020 | $135,000,000 |
Faze Medicines is a biotechnology company harnessing the groundbreaking new science of biomolecular condensates to create medical breakthroughs. | Cambridge | MA | 20 - 50 | 2020 | $81,000,000 |
Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS). The company was founded in 2020 and is based in Somerville, Massachusetts, United States. | Cambridge | MA | 5 - 10 | 2020 | $1,500,000 |
Carbon Counts is creating a unique mobile game that will engage people to individually and collectively impact climate change | Cambridge | MA | 20 - 50 | 2020 | $7,000,000 |
TalkTo Inc. develops mobile applications. The Company offers an application that enables users to text directly to stores, restaurants, hotels, and other types of businesses. TalkTo serves the consumer discretionary sector. | Cambridge | MA | 5 - 20 | 2020 | $3,000,000 |
Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or iron-dependent cell death, a | Cambridge | MA | 20 - 50 | 2020 | $60,000,000 |
Thymmune Therapeutics is a preclinical biotechnology company based in Cambridge, MA applying proprietary insights in thymic engineering to develop and commercialize immune cell therapy products addressing significant opportunities with unmet clinical need | Cambridge | MA | 5 - 10 | 2019 | $44,000,000 |
Metrika is a monitoring and analytics platform that provides visibility and actionable insights into blockchain networks. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts, United States. | Cambridge | MA | 20 - 100 | 2019 | $21,700,000 |
Satellite Biosciences is leading the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases. Building | Cambridge | MA | 20 - 50 | 2019 | $101,470,992 |
SYSO Technologies provides end-to-end renewable energy and storage management technology and services. | Cambridge | MA | 20 - 50 | 2019 | $10,065,000 |
Myeloid Therapeutics is an immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases. | Cambridge | MA | 50 - 100 | 2019 | |
Akkio is a technology company that makes AI easy enough for anyone to use. | Cambridge | MA | 20 - 50 | 2019 | $18,000,000 |
Einblick is a visual data computing platform that provides the fastest way for organizations to understand the past, predict the future, and make the best data-driven decisions for their business. Einblick customers include a large luxury German car brand, | Cambridge | MA | 20 - 50 | 2019 | $6,000,000 |
Salient Predictions uses ML & ocean data to provide long range weather forecast for use in diverse industries. | Cambridge | MA | 20 - 50 | 2019 | $8,647,187 |
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics. | Cambridge | MA | 10 - 50 | 2019 | $5,300,000 |
Safar Partners is a seed- to growth-stage venture fund. | Cambridge | MA | 20 - 50 | 2019 | |
Meter is a next-generation volumetric imaging technology in development. | Cambridge | MA | 50 - 200 | 2019 | $67,500,000 |
Watershed Informatics catalyzes discovery by democratizing access to bioinformatics tools for biologists. It enables life sciences organizations of any size to perform mission-critical bioinformatics analyses (such as bulk, single-cell, and spatial transcr | Cambridge | MA | 5 - 20 | 2019 | $16,200,000 |
Elemind is developing noninvasive neurotechnology to augment sleep, attention, and ultimately the human experience. | Cambridge | MA | 5 - 20 | 2019 | $12,000,000 |
Vedere is developing cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss from Inherited Retinal Degenerations (IRDs), as well as other causes of both genetic and non-genetic vision loss. While the vast | Cambridge | MA | 10 - 50 | 2019 | $98,000,000 |
Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging | Cambridge | MA | 50 - 100 | 2019 | $136,200,000 |
A cancer diagnosis is something no one wants to hear. Too often, cancer is detected late, once it has spread and treatment options are limited. But cancer can be more effectively treated with an intent to cure if caught in the earlier stages. At Thrive, an | Cambridge | MA | 100 - 500 | 2019 | $367,000,000 |
EQRx is committed to making innovative medicines at dramatically lower prices for the benefit of people and society. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the compan | Cambridge | MA | 200 - 500 | 2019 | $1,900,000,000 |
Our mission is to cure disease by writing the code of life | Cambridge | MA | 200 - 500 | 2018 | |
Malta Inc provides energy storage systems. The Company offers electro-thermal energy storage system that collects and stores energy from any power generation source like wind, solar, and fossil fuels. Malta serves customers in the State of Massachusetts. | Cambridge | MA | 50 - 500 | 2018 | $108,512,800 |
Venture capital for tomorrow’s greatest healthcare companies | Cambridge | MA | 10 - 50 | 2018 | |
Gain supply chain visibility and agility with Factor's Supplier Relationship Management System. | Cambridge | MA | 20 - 50 | 2018 | $24,000,000 |
Invaio Sciences is a technology company that is dedicated to unlocking the potential of our planet’s interdependent natural systems to solve pressing agriculture, nutrition, and environmental challenges. Invaio Sciences is a flagship pioneering company sta | Cambridge | MA | 100 - 500 | 2018 | $138,900,000 |
Compt is a perk management software that helps companies build & scale flexible perk stipends.
With Compt, you can create:
- Remote work stipends
- Health & wellness stipends
- Learning & development stipends
- Equipment stipends
- Meal plan stipends
- S | Cambridge | MA | 20 - 50 | 2018 | $14,500,000 |
PiiQ RISK; Spear : Deliver the most advanced SPEAR PHISHING attack simulations with complete automation! Advanced Attack protocols, contextualised by end user with complete automation and intuitive management consoles - no experience required! Truly tailor | Cambridge | MA | 10 - 50 | 2018 | $4,500,000 |
Alltrna is the tRNA platform company to decipher tRNA biology and pioneer tRNA therapeutics to treat thousands of diseases. tRNAs play a central role in the translation of mRNA into proteins. tRNA biology modulates the complex code of DNA and RNA across tr | Cambridge | MA | 50 - 100 | 2018 | $159,000,000 |
Loading...
Discover job listings, tech companies, startups, investors, job listings, funding rounds, industries, and tech stacks.
Get EmployblBook a demo callAND/OR
Get periodic emails about startups and the tech job market
Employbl Newsletter is about helping you find jobs and understand the tech job market. Read previous issues.